Prospective study of perinatal transmission of Chlamydia trachomatis.
During a five-year period, 262 (4.7%) of 5,531 pregnant women had positive cervical cultures for Chlamydia trachomatis, and 131 of their infants were followed up prospectively to ascertain the outcome of chlamydial exposure during the birth process. Culture-confirmed inclusion conjunctivitis of the newborn was seen in 23 (18%) of the infants. Chlamydial pneumonia was diagnosed in 21 (16%) of the infants at risk. Chlamydia trachomatis was recovered from 47 of the infants (36%), while 79 (60%) showed serologic evidence of infection. Subclinical rectal and vaginal infections were detected in 14% of infants at risk. In our population, 2.8% of newborn infants show serologic evidence of perinatal chlamydial infection and 1.4% develop either chlamydial pneumonia or conjunctivitis. Incidence rates of this magnitude indicate the need for programs aimed at preventing perinatal transmission of C trachomatis.
Schachter
J
J
Grossman
M
M
Sweet
R L
RL
Holt
J
J
Jordan
C
C
Bishop
E
E
D000907:Antibodies, Bacterial / Q000032:analysis; D002690:Chlamydia Infections / Q000151:congenital / Q000635:transmission*; D002692:Chlamydia trachomatis / Q000276:immunology / Q000302:isolation & purification; D003235:Conjunctivitis, Inclusion / Q000188:drug therapy / Q000635:transmission; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007223:Infant; D007231:Infant, Newborn; D009878:Ophthalmia Neonatorum / Q000188:drug therapy / Q000635:transmission; D011014:Pneumonia / Q000382:microbiology / Q000635:transmission; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000635:transmission*; D011446:Prospective Studies
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D004917:Erythromycin